NewsBenzingaMedicus Pharma Files Optimized Seamless Phase 2b/3 Registration-Intent Protocol To FDA For Teverelix To Treat Advanced Prostate Cancer Medicus Pharma Files Optimized Seamless Phase 2b/3 Registration-Intent Protocol To FDA For Teverelix To Treat Advanced Prostate Cancer Benzinga 2026.09.29 11:31 (GMT+0) Open on Benzinga Other news 21Shares Forecasts Bitcoin to Hit New Highs in 2027 Predictions List Stock of the Day: How Low Will Micron Go? ANT, NVDA, PANW and More: 5 Stocks Investors Couldn't Stop Buzzing About This Week Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet Consumer Tech (Nov 16-20): Anthropic Makes A Smashing Debut, GTA 6 Releases & More Abdul El-Sayed to Meet JD Vance? From ‘Very, Very Evil’ to Potential White House Talks: Report